Amylyx Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Amylyx Pharmaceuticals

09/05/2024 14:31

* Amylyx Pharmaceuticals Inc  AMLX.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of 2 cents.  The mean expectation of five analysts
for the quarter was for a loss of one cent per share. Wall
Street expected results to range from -38 cents to 32 cents per
share.
    * Revenue rose 24.1% to $88.64 million from a year ago;
analysts
expected $98.35 million. 
    * Amylyx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.75​.
    * The company reported a quarterly loss of $118.79 million.
    * Amylyx Pharmaceuticals Inc shares had fallen by 32.0% this
quarter and lost 86.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 102.1% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Amylyx
Pharmaceuticals Inc is $3.75 
This summary was machine generated from LSEG data May 9 at 01:30
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.01          -0.12          Missed
 Dec. 31 2023      0.23           0.07           Missed
 Sep. 30 2023      0.44           0.30           Missed
 Jun. 30 2023      0.10           0.31           Beat